Clinical Development DNA Medicine Radiology 
Worldwide Clinical Trials
JULY 8, 2024
With radiopharmaceuticals emerging as a diagnostic and therapeutic (theranostics) procedure, many are in the clinical development pipeline and are expected to play a crucial role in the future of healthcare. Genetic Factors : Certain genetic mutations, such as those in DNA repair genes, can affect how cells respond to radiation.
XTalks
JANUARY 19, 2024
Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer. There have been more than $1.7
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JUNE 28, 2021
The companies acquired by Bayer, Noria and PSMA Therapeutics, have exclusive world-wide rights to technology licensed from Weill Cornell Medicine (New York, NY, USA) and Johns Hopkins University (Baltimore, MD, USA). Noria was founded by Dr. John Babich, Chief, Radiopharmaceutical Sciences in Radiology at Weill Cornell Medicine.
Intouch Solutions
SEPTEMBER 27, 2024
The discourse wasn’t just about cycling through tissue or aiding clinical development; it ranged from mutation prediction to tumor microenvironment (TME) analysis to how AI can aid in diagnosis and treatment planning to achieve better outcomes for patients. Anne Marie, any insights into the unique trends at ESMO 2024?
XTalks
SEPTEMBER 14, 2020
President Jair Bolsonara recently admitted that he, too has tested positive for COVID-19 and he, like Trump, believes in the medicinal power of hydroxychloroquine, despite good evidence to the contrary. Below are some free webinars you can register for that have delved into the topic: Continuing Clinical Research Innovations After COVID-19.
Expert insights. Personalized for you.
130 
Let's personalize your content